Abstract
We evaluated the association of soyfood intake and breast cancer risk in a population-based case–control study among Chinese women in Shanghai. Included in the study were 1459 cases and 1556 age-matched controls, with respective response rates of 91.1% and 90.3%. Usual soyfood intake was assessed using a food frequency questionnaire (FFQ). Separate analyses were performed for all subjects and for the subset who reported no recent change in soyfood intake. The intake levels of soyfoods among women in Shanghai are high, with 96.6% women reporting soyfood consumption at least once a week. A statistically non-significant reduced risk (odds ratio (OR) = 0.78 95% CI = 0.52–1.16) of breast cancer was observed among those who reported eating soyfood at least once a week. Compared to those in the lowest decile intake group, women in the highest decile intake group had a 30% reduced risk of breast cancer (OR = 0.66, 95% CI = 0.46–0.95), but no monotonic dose–response relation was observed (P for trend, 0.28). Stratified analyses showed that the inverse association was restricted primarily among women who had a high body mass index (BMI), with an adjusted OR of 0.30 (95% CI = 0.10–0.94) observed for the highest intake group. The reduction in risk was stronger for breast cancer positive for both oestrogen receptor (ER) and progesterone receptor (PR) (OR = 0.44, 95% CI = 0.25–0.78) than those with other ER/PR status. More pronounced inverse associations were observed in analyses among those who reported no recent change in soyfood intake than those conducted in all subjects. A dose–response relation between soyfood intake and breast cancer risk was observed in this subset of women (P for trend, 0.02), with an OR of 0.46 (95%CI = 0.28–0.75) for those in the highest decile intake group. No clear monotonic dose–response relation was found between soyfood intake and breast cancer risk among regular soy eaters, but nevertheless the results suggest that regular soyfood consumption may reduce the risk of breast cancer, particularly for those positive for ER and PR; the effect may be modified by body mass index. © 2001 Cancer Research Campaign
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Adlercreutz H and Mazur W (1997) Phyto-oestrogens and Western diseases. Ann Med 29: 95–120
Breslow NE and Day NE (1980) Statistical methods in cancer research. The analysis of case-control studies, Lyon (France): International Agency for Research on Cancer
Bruning PF, Bonfrer JM, van Noord PA, Hart AA, Jong-Bakker M and Nooijen WJ (1992) Insulin resistance and breast-cancer risk. Int J Cancer 52: 511–516
Chen Z, Zheng W, Custer LJ, Dai Q, Shu XO, Jin F and Franke AA (1999) Usual dietary consumption of soy foods and its correlation with the excretion rate of isoflavonoids in overnight urine samples among Chinese women in Shanghai. Nutr Cancer 33: 82–87
Chinese Academy of Medical Sciences (1991). Food Composition Tables, Beijing: People's Health Publishing House
Constantinou AL, Rossi H, Nho CW, Jefferey EH, Xu XY, Breemen RBV and Pezzuto JM (2000) Soy protein isolate depleted fo isoflavones prevents DMBA-induced mammary tumors in female rats. AACR meeting,
Duncan AM, Underhill KE, Xu X, Lavalleur J, Phipps WR and Kurzer MS (1999) Modest hormonal effects of soy isoflavones in postmenopausal women [published erratum appears in J Clin Endocrinol Metab 2000 Jan; 85(1): 448]. J Clin Endocrinol Metab 84: 3479–3484
Greenstein J, Kushi L, Zheng W, Fee R, Campbell D, Campbell D, Sellers T and Folsom A (1996) Risk of breast cancer associated with intake of sepcific foods and food groups. Am J Epidemiol 143: S36
Hankinson SE, Willett WC, Colditz GA, Hunter DJ, Michaud DS, Deroo B, Rosner B, Speizer FE and Pollak M (1998) Circulating concentrations of insulin-like growth factor-I and risk of breast cancer [see comments]. Lancet 351: 1393–1396
Henderson BE, Pike MC, Bernstein L and Whelen SL (1996) Breast Cancer. Cancer Epidemiology and Prevention, Schottenfeld D, Parkin DM (eds), pp 1022–1039, Oxford University Press: New York
Hirayama T (1990). Life-style and mortality: a large-scale census-based cohort study in Japan, Wahrendorf J (ed). Basel: Karger
Hirohata T, Shigematsu T, Nomura AM, Nomura Y, Horie A and Hirohata I (1985) Occurrence of breast cancer in relation to diet and reproductive history: a case-control study in Fukuoka, Japan. Natl Cancer Inst Monogr 69: 187–190
Hirose K, Tajima K, Hamajima N, Inoue M, Takezaki T, Kuroishi T, Yoshida M and Tokudome S (1995) A large-scale, hospital-based case-control study of risk factors of breast cancer according to menopausal status. Jpn J Cancer Res 86: 146–154
Kelly GE, Joannou GE, Reeder AY, Nelson C and Waring MA (1995) The variable metabolic response to dietary isoflavones in humans. Proc Soc Exp Biol Med 208: 40–43
Key TJ, Sharp GB, Appleby PN, Beral V, Goodman MT, Soda M and Mabuchi K (1999) Soya foods and breast cancer risk: a prospective study in Hiroshima and Nagasaki, Japan. Br J Cancer 81: 1248–1256
Lee HP, Gourley L, Duffy SW, Esteve J, Lee J and Day NE (1991) Dietary effects on breast-cancer risk in Singapore [see comments]. Lancet 337: 1197–1200
Lee HP, Gourley L, Duffy SW, Esteve J, Lee J and Day NE (1992) Risk factors for breast cancer by age and menopausal status: a case-control study in Singapore. Cancer Causes Control 3: 313–322
Lu LJ, Anderson KE, Grady JJ, Kohen F and Nagamani M (2000) Decreased ovarian hormones during a soya diet: implications for breast cancer prevention. Cancer Res 60: 4112–4121
Messina M, Barnes S and Setchell KD (1997) Phyto-oestrogens and breast cancer [comment]. Lancet 350: 971–972
Parkin DM, Whelen SL, Ferlay J and Raymond L (1997). Cancer Incidence in Five Continents, Lyon: International Agency for Research on Cancer
Pasquali R, Antenucci D, Melchionda N, Fabbri R, Venturoli S, Patrono D and Capelli M (1987) Sex hormones in obese premenopausal women and their relationships to body fat mass and distribution, B cell function and diet composition. J Endocrinol Invest 10: 345–350
Pino AM, Valladares LE, Palma MA, Mancilla AM, Yanez M and Albala C (2000) Dietary isoflavones affect sex hormone-binding globulin levels in postmenopausal women. J Clin Endocrinol Metab 85: 2797–2800
Potischman N, Swanson CA, Coates RJ, Weiss HA, Brogan DR, Stanford JL, Schoenberg JB, Gammon MD and Brinton LA (1997) Dietary relationships with early onset (under age 45) breast cancer in a case-control study in the United States: influence of chemotherapy treatment [see comments]. Cancer Causes Control 8: 713–721
Potischman N, Swanson CA, Coates RJ, Gammon MD, Brogan DR, Curtin J and Brinton LA (1999) Intake of food groups and associated micronutrients in relation to risk of early-stage breast cancer. Int J Cancer 82: 315–321
Potter JD, Cerhan JR, Sellers TA, McGovern PG, Drinkard C, Kushi LR and Folsom AR (1995) Progesterone and estrogen receptors and mammary neoplasia in the Iowa Women's Health Study: how many kinds of breast cancer are there?. Cancer Epidemiol Biomarkers Prev 4: 319–326
Satia JA, Patterson RE, Herrero R, Jin F, Dai Q, King IB, Chen C, Kristal AR, Prentice RL and Rossing MA (1999) Study of diet, biomarkers and cancer risk in the United States, China and Costa Rica. Int J Cancer 82: 28–32
Seidell JC (2000) Obesity, insulin resistance and diabetes–a worldwide epidemic. Br J Nutr 83 Suppl 1: S5–S8
Siiteri PK (1987) Adipose tissue as a source of hormones. Am J Clin Nutr 45: 277–282
Thorsen T, Lahooti H, Rasmussen M and Aakvaag A (1992) Oestradiol treatment increases the sensitivity of MCF-7 cells for the growth stimulatory effect of IGF-I. J Steroid Biochem Mol Biol 41: 537–540
Wagner JD, Cefalu WT, Anthony MS, Litwak KN, Zhang L and Clarkson TB (1997) Dietary soy protein and estrogen replacement therapy improve cardiovascular risk factors and decrease aortic cholesteryl ester content in ovariectomized cynomolgus monkeys. Metabolism 46: 698–705
Willett WC (1998). Nutritional Epidemiology: Monographs in Epidemiology and Biostatistics, Oxford: New York
Witte JS, Ursin G, Siemiatycki J, Thompson WD, Paganini-Hill A and Haile RW (1997) Diet and premenopausal bilateral breast cancer: a case-control study. Breast Cancer Res Treat 42: 243–251
Wu AH, Ziegler RG, Horn-Ross PL, Nomura AM, West DW, Kolonel LN, Rosenthal JF, Hoover RN and Pike MC (1996) Tofu and risk of breast cancer in Asian-Americans. Cancer Epidemiol Biomarkers Prev 5: 901–906
Wu AH, Ziegler RG, Nomura AM, West DW, Kolonel LN, Horn-Ross PL, Hoover RN and Pike MC (1998) Soy intake and risk of breast cancer in Asians and Asian Americans. Am J Clin Nutr 68: 1437S–1443S
Yang G, Zheng W, Lu G, Dai Q, Best R, Gao YT, SHu XO, Shrubsole M and Jin F (2001). Am Ass Cancer Res,
Yuan JM, Wang QS, Ross RK, Henderson BE and Yu MC (1995) Diet and breast cancer in Shanghai and Tianjin, China. Br J Cancer 71: 1353–1358
Zheng W, Dai Q, Custer LJ, Shu XO, Wen WQ, Jin F and Franke AA (1999) Urinary excretion of isoflavonoids and the risk of breast cancer. Cancer Epidemiol Biomarkers Prev 8: 35–40
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Dai, Q., Shu, XO., Jin, F. et al. Population-based case–control study of soyfood intake and breast cancer risk in Shanghai. Br J Cancer 85, 372–378 (2001). https://doi.org/10.1054/bjoc.2001.1873
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.2001.1873
Keywords
This article is cited by
-
Isoflavone intake on the risk of overall breast cancer and molecular subtypes in women at high risk for hereditary breast cancer
Breast Cancer Research and Treatment (2020)
-
Validity and reliability of a food frequency questionnaire for assessing dietary intake among Shanghai residents
Nutrition Journal (2019)
-
Helminthostachys zeylanica alleviates hepatic steatosis and insulin resistance in diet-induced obese mice
BMC Complementary and Alternative Medicine (2019)
-
DUSP1 promoter methylation in peripheral blood leukocyte is associated with triple-negative breast cancer risk
Scientific Reports (2017)
-
Equol as a potent radiosensitizer in estrogen receptor-positive and -negative human breast cancer cell lines
Breast Cancer (2015)